9Romero RA, Ponce HC, Ciprian A, et al. Immunomodulatroy properties of mycoplasma Pulmonis I characterization of the immunomodulatory activity[J]. Int Immunopharmcol, 2001,1(910): 1 679～ 1 688.
10Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-al-pha[J ] .Circulation, 1998,97(14): 1 375～ 1 381.
6Chaudhry R,Nisar N,Hora B,et al.Expression and immunological characterization of the carboxy-terminal region of the P1 adhesin protein of Mycoplasma pneumoniae[J].J Clin Microbiol,2005,43(1):321.
7Stelmach I,Podsiad M,Grzelewski T.Humoral and cellular immunity in children with Mycoplasma pneumoniae infection:a 1-year prospective study[J].Clin Diagn Lab Immunol,2005,12(10):1246.
8Nisar N,Guleria R,Kumar S,et al.Mycoplasma pneumoniae and its role in asthma[J].Postgrad Med J,2007,83(976):100.
9Koh YY,Park Y,Lee H,et al.Levels of interleukin-2,interferon-γ,and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia:implication of tendency toward increased immunoglobulin E production[J].Pediatrics,2001,107(3):E39.
10Chu HW,Honour JM,Rawlinson CA,et al.Effects of respiratory Mycoplasma pneumoniae infection on allergen induced bronchial hyperresponsiveness and lung inflammation in mice[J].Infect Immun,2003,71(3):1520.
